Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Nose

Showing results (311-320 of 312) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 312 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 31, 2000
[Interim report of JFMTC study no. 20 on the effectiveness of high dose CDDP plus 5-FU regimen as an adjuvant therapy for far-advanced cancer of the stomach]T Toge, M Fujita, K Hirata, et al.
European Journal of Neurology|July 17, 2019
Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravisY Nishida, Y K Takahashi, T Kanai, et al.
Pageof 32

Showing results (311-320 of 312) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 312 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 31, 2000
[Interim report of JFMTC study no. 20 on the effectiveness of high dose CDDP plus 5-FU regimen as an adjuvant therapy for far-advanced cancer of the stomach]T Toge, M Fujita, K Hirata, et al.
European Journal of Neurology|July 17, 2019
Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravisY Nishida, Y K Takahashi, T Kanai, et al.
Pageof 32